JEITO appoints Principal
JEITO, a new independent French private equity firm dedicated to the biotech and biopharma sectors, has appointed Mehdi Ainouche as Principal.
With nearly five years experience in the financing of innovation within health and biotechnology, Ainouche's primary role will be to develop sourcing and to support the selection and final negotiations with companies entering the portfolio.
Subsequently, following the Jeito model, Mehdi will provide support for these future unicorns in order to accelerate their growth towards the commercialisation of major medical innovations, thus promoting patients' access to cutting-edge treatment.
Ainouche joins the JEITO investment team, which currently comprises nine people.